ALLR
Allarity Therapeutics
ALLR
ALLR
2 hedge funds and large institutions have $33.3K invested in Allarity Therapeutics in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
$23.9K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
$9.43K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $23.9K | +$23.9K | +6 | New |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $9.43K | +$9.43K | +2 | New |
|
3
Wells Fargo
San Francisco,
California
| $33 | -$8 | – | – |
|
4
Morgan Stanley
New York
| – | -$7 | – | – |
|
5
Bank of America
Charlotte,
North Carolina
| – | -$32 | – | – |
|
6
Acadian Asset Management
Boston,
Massachusetts
| – | -$2K | – | – |
|